| ASSET | YEAR | % RETURN |
|---|---|---|
Genmab A-S (GMAB) | 2009 | -59.97% |
Huntington Bancshares (HBAN) | 2009 | -52.98% |
Citigroup (C) | 2009 | -51.7% |
T-Mobile US (TMUS) | 2009 | -48.89% |
Mizuho Financial (MFG) | 2009 | -43.92% |
Natwest (NWG) | 2009 | -35.77% |
KeyCorp (KEY) | 2009 | -33.77% |
Regions Financial (RF) | 2009 | -32.74% |
Sumitomo Mitsui Financial (SMFG) | 2009 | -29.89% |
Alnylam Pharmaceuticals (ALNY) | 2009 | -28.87% |
Lloyds Banking Group PLC ADR (LYG) | 2009 | -24.25% |
Fidelity National Financial (FNF) | 2009 | -24% |
Vulcan Materials (VMC) | 2009 | -23.57% |
Jacobs Solutions (J) | 2009 | -23.18% |
Valero Energy (VLO) | 2009 | -22.77% |
Kroger (KR) | 2009 | -21.19% |
W R Berkley (WRB) | 2009 | -19.88% |
Mitsubishi UFJ Financial Group Inc ADR (MUFG) | 2009 | -19.1% |
Nasdaq (NDAQ) | 2009 | -19.04% |
Axon Enterprise (AXON) | 2009 | -17.36% |
Aon (AON) | 2009 | -15.74% |
Takeda Pharmaceutical Co Ltd ADR (TAK) | 2009 | -15.46% |
Neurocrine Biosciences (NBIX) | 2009 | -15.26% |
Gilead Sciences (GILD) | 2009 | -14.99% |
Cheniere Energy (LNG) | 2009 | -14.79% |
Large-cap stocks are treated as having a market cap of $10B+.
